Clinical Trials · NCT07793019
IBI3042 Study in Healthy Participants and Overweight or Obese Participants
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Enrollment
- 104
- Start date
- Sep 2026
- Locations
- 1 site, China
- Primary endpoint
- Number of Participants With Adverse Events (Part A)